Therefore, the understanding of crosstalk between Raf/MAPK/ERK1/2 and PI3K/AKT signal pathways during brain ischemia/reperfusion may eventually lead to the development of new therapeutic strategy for the disease. This evidence concerns the gene RAF1 and brain ischemia.